Iljazi, Afrim
Ashina, Håkan
Al-Khazali, Haidar Muhsen
Lipton, Richard B.
Ashina, Messoud
Schytz, Henrik W.
Ashina, Sait http://orcid.org/0000-0003-3973-6640
Article History
Received: 29 November 2019
Accepted: 7 May 2020
First Online: 15 May 2020
Compliance with ethical standards
:
: All authors have completed the ICMJE uniform disclosure form at ExternalRef removed and declare: Afrim Iljazi, Hakan Ashina, and Haidar Muhsen Al-Khazali have no support from any organization for the submitted work; no financial relationships with any organizations that might have an interest in the submitted work in the previous 3 years; no other relationships or activities that could appear to have influenced the submitted work. Richard B. Lipton is the Edwin S. Lowe Professor of Neurology at the Albert Einstein College of Medicine in New York. He receives research support from the NIH: 2PO1 AG003949 (Multiple Principal Investigator), 5U10 NS077308 (Principal Investigator), RO1 NS082432 (Investigator), 1RF1 AG057531 (Site Principal Investigator), RF1 AG054548 (Investigator), 1RO1 AG048642 (Investigator), R56 AG057548 (Investigator), K23 NS09610 (Mentor), K23AG049466 (Mentor), and 1K01AG054700 (Mentor). He also receives support from the Migraine Research Foundation and the National Headache Foundation. He serves on the editorial board of Neurology, senior advisor to Headache, and associate editor to Cephalalgia. He has reviewed for the NIA and NINDS; holds stock options in eNeura Therapeutics and Biohaven Holdings; and serves as consultant, advisory board member, or has received honoraria from the American Academy of Neurology, Alder, Allergan, American Headache Society, Amgen, Autonomic Technologies, Avanir, Biohaven, Biovision, Boston Scientific, Dr Reddy’s, Electrocore, Eli Lilly, eNeura Therapeutics, GlaxoSmithKline, Merck, Pernix, Pfizer, Supernus, Teva, Trigemina, Vector, and Vedanta. He receives royalties from Wolff’s Headache, 7th and 8th Edition, Oxford Press University, 2009, Wiley and Informa. Messoud Ashina is a consultant, speaker, or scientific adviser for Alder, Allergan, Amgen, Eli Lilly, Novartis, and Teva. Henrik Winther Schytz has received consultant fees from Teva, Novartis, and BalancAir and received grants from Novartis. Sait Ashina has received consulting fees from Novartis, Amgen, Allergan, Elly Lilly, Supernus, Satsuma, Percept Promius, and Theranica.
: None